[go: up one dir, main page]

NO941698L - Collagenaseinhibitor - Google Patents

Collagenaseinhibitor

Info

Publication number
NO941698L
NO941698L NO941698A NO941698A NO941698L NO 941698 L NO941698 L NO 941698L NO 941698 A NO941698 A NO 941698A NO 941698 A NO941698 A NO 941698A NO 941698 L NO941698 L NO 941698L
Authority
NO
Norway
Prior art keywords
alkyl
nhch
cancer
collagenaseinhibitor
collagenase
Prior art date
Application number
NO941698A
Other languages
English (en)
Other versions
NO306507B1 (no
NO941698D0 (no
Inventor
Yukio Sugimura
Kazuhiko Tamaki
Tomowo Kobayashi
Kazuhiko Tanzawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO941698D0 publication Critical patent/NO941698D0/no
Publication of NO941698L publication Critical patent/NO941698L/no
Publication of NO306507B1 publication Critical patent/NO306507B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO941698A 1991-11-08 1994-05-06 Kollagenaseinhibitor NO306507B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29288491 1991-11-08
PCT/JP1992/001420 WO1993009097A1 (fr) 1991-11-08 1992-11-02 Inhibiteur de la collagenase

Publications (3)

Publication Number Publication Date
NO941698D0 NO941698D0 (no) 1994-05-06
NO941698L true NO941698L (no) 1994-07-07
NO306507B1 NO306507B1 (no) 1999-11-15

Family

ID=17787629

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941698A NO306507B1 (no) 1991-11-08 1994-05-06 Kollagenaseinhibitor

Country Status (17)

Country Link
US (1) US5643908A (no)
EP (1) EP0621270B1 (no)
JP (2) JPH05194414A (no)
KR (1) KR100255203B1 (no)
AT (1) ATE191713T1 (no)
AU (1) AU661058B2 (no)
CA (1) CA2123104A1 (no)
CZ (1) CZ112694A3 (no)
DE (1) DE69230916T2 (no)
DK (1) DK0621270T3 (no)
ES (1) ES2145014T3 (no)
FI (1) FI942094A7 (no)
GR (1) GR3033368T3 (no)
HU (1) HUT67374A (no)
NO (1) NO306507B1 (no)
RU (1) RU2091373C1 (no)
WO (1) WO1993009097A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
BR9506535A (pt) * 1994-01-20 1997-09-16 British Biotech Pharm Inibidores de metaloproteinases
AU2394795A (en) * 1994-04-28 1995-11-29 Du Pont Merck Pharmaceutical Company, The Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
GB9411598D0 (en) * 1994-06-09 1994-08-03 Hoffmann La Roche Hydroxamic acid derivatives
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors
US5919940A (en) * 1995-01-20 1999-07-06 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5917090A (en) * 1995-06-30 1999-06-29 British Biotech Pharmaceuticals Ltd. Matrix metalloproteinase inhibitors
US6127427A (en) 1995-11-23 2000-10-03 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
AU2090897A (en) * 1996-02-29 1997-09-16 Mikael Bols Hydroxyhexahydropyridazines
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
US6953788B1 (en) 1996-09-19 2005-10-11 Aventis Pharmaceuticals Inc. 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
GB9803005D0 (en) 1998-02-12 1998-04-08 British Biotech Pharm Anti-inflammatory agents
US7253169B2 (en) * 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US6797820B2 (en) 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
DE60219630T2 (de) * 2001-06-15 2007-12-27 Vicuron Pharmaceuticals, Inc., Fremont Bicyclische pyrrolidinverbindungen
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
US20030068655A1 (en) * 2001-09-12 2003-04-10 Protiveris, Inc. Microcantilever apparatus and methods for detection of enzymes
FR2835835B1 (fr) * 2002-02-11 2004-04-16 Aventis Pharma Sa Nouveaux derives de la pyridazine, leur utilisation comme medicaments, compositions pharmaceutiques et leur procede de preparation
US7807177B2 (en) 2004-01-27 2010-10-05 Toshikazu Nakamura Segment of glycosylation-deficient HGFalpha-chain
US20090176996A1 (en) * 2008-01-07 2009-07-09 Ahmed Abdel-Magid Process for the preparation of sulfamide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659711A (en) * 1983-01-31 1987-04-21 Usv Pharmaceutical Corporation 1,2,3,4-Tetrahydrophthalazine and hexahydropyridazine compounds for treating hypertension
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
JPH0670019B2 (ja) * 1989-07-21 1994-09-07 明治製菓株式会社 新抗生物質sf2197c物質およびその製造法
JPH03157372A (ja) * 1989-11-13 1991-07-05 Yamanouchi Pharmaceut Co Ltd Yl―01869p物質及びその製造法
WO1991017982A1 (en) * 1990-05-21 1991-11-28 Sankyo Company, Limited Novel compound matristatin
AU2228292A (en) * 1991-06-14 1993-01-12 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor

Also Published As

Publication number Publication date
US5643908A (en) 1997-07-01
CA2123104A1 (en) 1993-05-13
CZ112694A3 (en) 1994-12-15
DE69230916D1 (de) 2000-05-18
EP0621270B1 (en) 2000-04-12
ATE191713T1 (de) 2000-04-15
EP0621270A1 (en) 1994-10-26
JPH05194415A (ja) 1993-08-03
ES2145014T3 (es) 2000-07-01
AU661058B2 (en) 1995-07-13
HU9401420D0 (en) 1994-08-29
NO306507B1 (no) 1999-11-15
AU2799392A (en) 1993-06-07
GR3033368T3 (en) 2000-09-29
EP0621270A4 (en) 1995-01-18
RU2091373C1 (ru) 1997-09-27
DK0621270T3 (da) 2000-07-17
DE69230916T2 (de) 2000-12-14
WO1993009097A1 (fr) 1993-05-13
NO941698D0 (no) 1994-05-06
JPH05194414A (ja) 1993-08-03
HUT67374A (en) 1995-03-28
KR100255203B1 (ko) 2000-05-01
FI942094A7 (fi) 1994-07-01
FI942094A0 (fi) 1994-05-06

Similar Documents

Publication Publication Date Title
FI942094A0 (fi) Kollagenaasin inhibiittori
KR960702464A (ko) Dc-89 유도체[dc-89 derivative]
ATE116973T1 (de) Substituierte thiazole und ihre anwendung als fungizide.
WO2000004014A1 (fr) Derives de pyrimidine manifestant une activite antitumorale
DK0839798T3 (da) Mellemforbindelser til at fremstille retrovirale-proteaseinhibitorer
DE69221794D1 (de) 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
EP0758653A4 (en) IMIDAZOQUINAZOLINE DERIVATIVES
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
MX9604398A (es) Derivados de sulfonamida.
IT1269176B (it) Eterobicicli ad attivita' fungicida
DK0641770T3 (da) Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet
ES2093091T3 (es) Derivado de glutation.
EP0600092A4 (en) Thiazole derivative.
IT1271443B (it) Derivati eterobiciclici ad attivita' fungicida
ATE105565T1 (de) Pradimicinderivate.
EP0466938A4 (en) High-molecular spiropyran compound
MY103004A (en) Azole derivatives
ITMI912421A1 (it) Derivati eterociclici di alcossiacrilati ad attivita' fungicida
DE69314573D1 (de) 2-Thiazolylpyrroleakrylate mit fungizider Wirkung
ATE112781T1 (de) Polyglukosiden aus hydroxyalkylsorbit.
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2002